Look up one drug

Ontario coverage, price, criteria word for word, Health Canada status and shortages for one product

Patient plan: look up a medication list

CARVEDILOL

All products: Limited Use (codes 183)

Other products in the same Health Canada class (C07A) — coverage varies; not interchangeable

  • Acebutolol (Sectral): general benefit, Not a benefit
  • Atenolol (Apo-Atenol): general benefit
  • Bisoprolol (Sandoz Bisoprolol Tablets): general benefit, Not a benefit
  • Metoprolol (Lopresor SR): general benefit, Not a benefit
  • Nadolol (Corgard): general benefit, Not a benefit
  • Propranolol (Inderal-LA): general benefit, Not a benefit

3 more in the class list below

Apo-Carvedilol · DIN 02247935 · 12.5mg · tablet

Limited Use — Reason for Use code 183 requiredDormant since 2026-05-13 · checked 2026-09-19 · What does dormant mean?
StatusLimited Use — Reason for Use code 183 required
Write on scriptLU code 183 (patient must meet the criteria below)
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
Ontario Limited Use criteria — code 183
Coverage limit: For patients with: Reason for Use code 183 a) NYHA Class II or III Congestive Heart Failure (CHF); and b) Currently being treated with an angiotensin converting enzyme (ACE) inhibitor, diuretics with or without digoxin, or previously treated, and failed these agents; and c) An ejection fraction less than or equal to 35%; and d) At least one episode of symptomatic CHF within a 12 month period while receiving optimal management. Coverage limit: LU Authorization Period: Indefinite
1 brand, same coverage
Apo-Carvedilol · DIN 02247935 Manufacturer: Apotex Inc.; listing date 2004-04-06 Daily cost (source): $0.4120 Health Canada: Dormant since 2026-05-13 · brand APO-CARVEDILOL · ATC C07AG02 CARVEDILOL · form Tablet · route Oral · ingredients CARVEDILOL 12.5 MG · company Apotex inc · schedule Prescription
Check this DIN again · Health Canada product record

Apo-Carvedilol: Formulary list price $0.2060/unit (unit not stated in source; not the patient's cost)

Ministry pays: $0.2060 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=72245 · Verify on the e-Formulary ↗ (DIN 02247935)

Source record
DIN 02247935: Apo-Carvedilol Raw flags: chronicUseMed=Y, sec12=Y, sec3=Y Item: 240400142; group id 278; item number 0578; lccId 00050; manufacturer id APX Source form: Tab; strength: 12.5mg Recorded listing: Limited Use: paid only with a Reason for Use code and the criteria below; chronic-use medication (100-day supply rule, dispensing-fee limit) Source prices (unrounded): $0.2060; ministry $0.2060 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02247935 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=72245
Interchangeable products
Auro-Carvedilol · DIN 02418517 · $0.2060 Carvedilol · DIN 02248754 · $0.2060 Carvedilol · DIN 02364948 · $0.2060 Coreg · DIN 02229652 · not recorded Jamp-Carvedilol · DIN 02368919 · $0.2060 PMS-Carvedilol · DIN 02245916 · $0.2060 Ran-Carvedilol · DIN 02268043 · $0.2060 Ratio-Carvedilol · DIN 02252325 · $0.2060
Shortage status: not checked (no credentials)
Health Canada lists this DIN as Dormant since 2026-05-13 — choose a marketed DIN from the same-category list.
Other drugs in the same formulary class (24:04 Cardiac Drugs) and how they are covered

Matched class: 24:04 Cardiac Drugs

Drug-class inventory only. Lists recorded Ontario formulary products, not every Canadian medication; does not recommend treatment. Covered without a code on the Ontario formulary: ATENOLOL, DIGOXIN, PROPAFENONE HCL Some products covered without a code (check the product listing): ACEBUTOLOL HCL, AMIODARONE HCL, AMLODIPINE, BISOPROLOL FUMARATE, DILTIAZEM HCL, DISOPYRAMIDE, FLECAINIDE ACETATE, METOPROLOL TARTRATE, MEXILETINE HCL, NADOLOL, NIFEDIPINE, PROPRANOLOL, SOTALOL HCL, TIMOLOL MALEATE, VERAPAMIL HCL 24:00 CARDIOVASCULAR DRUGS

RANOLAZINE

· 2 products · Off-Formulary Interchangeable, not an ODB benefit · strengths: 500mg · ER Tab Source: formulary-ed43-front-matter.txt Part V; ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26; class 24:00 24:04 Cardiac Drugs

ACEBUTOLOL HCL

· 9 products · Listed, not a benefit (3), General benefit (6) · strengths: 100mg, 200mg, 400mg · Tab

ATENOLOL

· 26 products · General benefit · strengths: 50mg, 100mg · Tab

BISOPROLOL FUMARATE

· 20 products · General benefit (18), Listed, not a benefit (2) · strengths: 1.25mg, 2.5mg, 5mg, 10mg · Tab

METOPROLOL TARTRATE

· 28 products · Listed, not a benefit (6), General benefit (22) · strengths: 100mg, 200mg, 50mg · LA Tab, Tab

NADOLOL

· 8 products · Listed, not a benefit (3), General benefit (5) · strengths: 40mg, 80mg, 160mg · Tab

PROPRANOLOL

· 19 products · Off-Formulary Interchangeable, not an ODB benefit (8), General benefit (7), Listed, not a benefit (4) · strengths: 60mg, 80mg, 120mg, 160mg, 10mg, 20mg, 40mg · LA Cap, Tab

SOTALOL HCL

· 10 products · Listed, not a benefit (2), General benefit (8) · strengths: 80mg, 160mg · Tab

TIMOLOL MALEATE

· 6 products · Listed, not a benefit (3), General benefit (3) · strengths: 5mg, 10mg, 20mg · Tab

NEBIVOLOL HYDROCHLORIDE

· 8 products · Off-Formulary Interchangeable, not an ODB benefit · strengths: 2.5mg, 5mg, 10mg, 20mg · Tab

AMIODARONE HCL

· 9 products · Listed, not a benefit (1), General benefit (8) · strengths: 200mg · Tab

AMLODIPINE

· 56 products · Limited Use, codes 645, 706 (1), Off-Formulary Interchangeable, not an ODB benefit (11), General benefit (44) · strengths: 1mg/mL, 2.5mg, 5mg, 10mg · Oral Sol, Tab Source: formulary-ed43-front-matter.txt Part V; ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26; class 24:04 and 9 more
Full class listing Related classes: 24:06 Antilipemic Drugs, 24:08 Hypotensive Drugs (For Diuretics See 40:28), 24:12 Vasodilating Drugs, 24:32 Renin-Angiotensin Aldosterone Inhibitors Same formulary class, not same indication: class membership alone does not establish equivalent uses.
What the Health Canada label says it is for
1 INDICATIONS pms-CARVEDILOL (carvedilol) is indicated:  for the treatment of mild, moderate or severe heart failure of ischemic or non-ischemic origin to increase survival and also, to reduce the combined risk of all-cause mortality and cardiovascular or non-cardiovascular hospitalizations In general, pms-CARVEDILOL is used in conjunction with diuretics and an ACE inhibitor, with or without digitalis. pms-CARVEDILOL should be prescribed by a Health professional experienced in the treatment of heart failure. 1.1 Pediatrics Pediatrics (under 18 years of age): No data are available to Health Canada; therefore, Health Canada has not authorized an indication for pediatric use. 1.2 Geriatrics Geriatrics (over 65 years of age): Evidence from clinical studies and experience suggests that use in the geriatric population is associated with differences in safety or effectiveness. https://pdf.hres.ca/dpd_pm/00065327.PDF PM date: April 4, 2022 Source product: PMS-CARVEDILOL; DIN 02245914; fetched 2026-09-10 Product monograph posted by Health Canada; excerpt for lookup only.
Health Canada: dormant products
Health Canada defines dormant products as: “products that were previously marketed in Canada but for which the manufacturer has suspended sale for period of at least 12 months.” (canada.ca, Sep 10, 2026 ↗)